The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).
|Number of pages||2|
|Journal||Journal of Neurology Neurosurgery and Psychiatry|
|Publication status||Published - 1994|
ASJC Scopus subject areas
- Psychiatry and Mental health
- Neuropsychology and Physiological Psychology